STOCK TITAN
  1. Home
  2. Sec-filings
  3. LUNG
  4. [EFFECT] Pulmonx Corp SEC Filing

[EFFECT] Pulmonx Corp SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: November 25, 2025 4:00 P.M.
Form: S-3
CIK: 0001127537
Company Name: Pulmonx Corp
File Number: 333-290560

Source: View Original Filing on SEC EDGAR

Pulmonx Corp

NASDAQ:LUNG

View LUNG Stock Overview →

LUNG Rankings

#5563 Ranked by Market Cap
N/A Ranked by Dividends

LUNG Latest News

Mar 4, 2026
Pulmonx Reports Fourth Quarter and Full Year 2025 Financial Results
Mar 4, 2026
Pulmonx Announces Closing of up to $60 Million Credit Facility
Feb 20, 2026
Pulmonx to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026
Dec 3, 2025
Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Nov 12, 2025
Pulmonx Reports Third Quarter 2025 Financial Results

LUNG Latest SEC Filings

Mar 27, 2026
[SCHEDULE 13G/A] Pulmonx Corp Amended Passive Investment Disclosure
Mar 10, 2026
[10-K] Pulmonx Corp Files Annual Report
Mar 9, 2026
[SCHEDULE 13G] Pulmonx Corp Passive Investment Disclosure (>5%)
Mar 4, 2026
[8-K] Pulmonx Corp Reports Material Event
Mar 4, 2026
[Form 4] Pulmonx Corp Insider Trading Activity

LUNG Stock Data

54.49M
37.47M
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
REDWOOD CITY